<DOC>
	<DOCNO>NCT02457403</DOCNO>
	<brief_summary>A prospective , randomized clinical trial compare blood product use bleed event endoscopic neurosurgical procedure patient cirrhosis coagulopathy : Rotational Thromboelastometry ( ROTEM ) vs. conventional therapy ( SCARLET ) .</brief_summary>
	<brief_title>Comparison Blood Product Use Bleeding Events During After Endoscopic Neurosurgical Procedures Patients With Cirrhosis Coagulopathy : Rotational Thromboelastometry Versus Conventional Therapy</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Patients 18 old , admitted hospital Patients clinically documented cirrhosis Patients coagulopathic ( INR &gt; 1.5 and/or platelet &lt; 50,000 ) Patients undergo endoscopic procedure neurosurgical procedure Patients must pregnant Patients must take anticoagulant antiplatelet medication ( exception ASA 81 mg heparin DVT prophylaxis ) Patients must active infection ( per PI discretion ) Patients must know hemostatic disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>